At a glance
- Originator Aventis
- Class Antimigraines
- Mechanism of Action Serotonin 1D receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 03 Feb 1997 No-Development-Reported for Migraine in USA (Unknown route)